InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

InspireMD (NASDAQ: NSPR) will present at the 25th Annual Needham Virtual Healthcare Conference on April 14, 2026 at 12:45 PM ET. A live audio webcast and archived recording will be available on the company’s Investors page.

According to InspireMD, the presentation will cover recent corporate developments and provide an investor update.

Key Figures

Conference edition: 25th Annual Presentation date: April 14 Presentation time: 12:45 pm ET

3 metrics

Conference edition 25th Annual Needham Virtual Healthcare Conference

Presentation date April 14 Company presentation at Needham conference

Presentation time 12:45 pm ET Scheduled InspireMD presentation slot

Market Reality Check

Price: $1.5900 Vol: Volume 11,806 is at 0.23x...

low vol

$1.5900 Last Close

Volume Volume 11,806 is at 0.23x the 20-day average of 52,175, indicating limited trading interest ahead of the conference. low

Technical Shares at $1.59 are trading below the 200-day MA of $2.10 and sit 45.77% under the 52-week high.

Peers on Argus

NSPR was unchanged while peers were mixed, with names like ICAD up 3.48% and BDM...

1 Up

NSPR was unchanged while peers were mixed, with names like ICAD up 3.48% and BDMD, PROF, RCEL down between 4–8%. One momentum peer (LUNG) screened higher, suggesting stock-specific trading rather than a coordinated sector move around this conference update.

Historical Context

5 past events · Latest: Mar 18 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Mar 18	Earnings results	Positive	+0.0%	Reported strong Q4 and 2025 revenue growth and provided 2026 guidance.
Mar 09	Earnings date set	Neutral	+0.6%	Announced timing and access details for Q4 and full‑year 2025 results.
Jan 20	Inducement grant	Neutral	+1.3%	Disclosed restricted stock inducement grant to a new non‑executive employee.
Jan 12	Clinical publication	Positive	-5.8%	Published C-GUARDIANS pivotal trial in JACC showing low adverse event rates.
Nov 24	Clinical study data	Positive	+1.6%	Highlighted CREST-2 results supporting carotid artery stenting benefits and CGuard data.

Pattern Detected

News flow has mostly aligned with price, though a prior strong clinical publication saw a negative reaction.

Recent Company History

Over the last several months, NSPR highlighted multiple milestones, including JACC publication of the C-GUARDIANS pivotal trial on Jan 12, 2026 and positive CREST-2 study read‑through on Nov 24, 2025. Financially, Q4 and full‑year 2025 results on Mar 18, 2026 showed strong revenue growth. Earlier HR and equity‑grant updates rounded out news flow. Today’s conference participation fits this pattern of ongoing investor‑relations and visibility efforts rather than a discrete financial or clinical catalyst.

Regulatory & Risk Context

Active S-3 Shelf

Shelf Active

Active S-3 Shelf Registration 2025-08-06

The company has an active S-3 shelf filed on 2025-08-06 expiring on 2028-08-06. The filing is currently marked as not effective and there is no recorded usage, so no takedowns have been disclosed from this shelf in the provided data.

Market Pulse Summary

This announcement highlights InspireMD’s participation in the 25th Annual Needham Virtual Healthcare...

Analysis

This announcement highlights InspireMD’s participation in the 25th Annual Needham Virtual Healthcare Conference on April 14 at 12:45 pm ET, emphasizing ongoing investor‑relations efforts rather than a new clinical or financial milestone. Against a backdrop of strong 2025 revenue growth but continuing losses and going‑concern risks noted in recent filings, investors may focus on management’s messaging, commercial progress for CGuard Prime, and any updates consistent with the existing S-3 shelf framework.

Key Terms

carotid stent

1 terms

carotid stent medical

"developer of the CGuard® Prime carotid stent system for the prevention of stroke"

A carotid stent is a small metal mesh tube placed inside a narrowed carotid artery in the neck to prop the vessel open and help restore normal blood flow to the brain, typically delivered through the blood vessels using a thin tube. For investors, it matters because regulatory approvals, clinical trial results, insurance coverage and surgical adoption drive device sales, pricing and legal risk—think of it like a scaffold that keeps a critical pipeline open, affecting demand and revenue for makers.

AI-generated analysis. Not financial advice.

MIAMI, March 31, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard^® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming 25th Annual Needham Virtual Healthcare Conference on Tuesday, April 14^th at 12:45 pm Eastern Time (ET).

A live audio webcast and an archive of the recording will be available through the Investors page of InspireMD’s corporate website at https://investors.inspiremd.com.

About InspireMD, Inc.
InspireMD seeks to utilize its proprietary MicroNet™ mesh technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD’s common stock is quoted on Nasdaq under the ticker symbol NSPR. We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.

Investor Contacts:
Webb Campbell
Gilmartin Group LLC
webb@gilmartinir.com
investor-relations@inspiremd.com

FAQ

When will InspireMD (NSPR) present at the 25th Annual Needham Virtual Healthcare Conference?

InspireMD will present on April 14, 2026 at 12:45 PM Eastern Time. According to InspireMD, the session is part of the conference program and will be streamed as a live audio webcast with an archived recording available afterward.

How can investors watch the InspireMD (NSPR) presentation on April 14, 2026?

Investors can access a live audio webcast and archived recording via InspireMD’s Investors page. According to InspireMD, the webcast will stream live on the scheduled date and a replay will be posted on the company’s investor website for later viewing.

What topics will InspireMD (NSPR) cover in its Needham conference presentation?

The presentation will provide an investor update and recent company developments. According to InspireMD, content will focus on corporate progress related to its CGuard Prime carotid stent system and overall business highlights for investors.

Will the InspireMD (NSPR) Needham presentation be available after the live event?

Yes, an archived recording will be available after the live webcast on the investor website. According to InspireMD, the company will post the audio replay on its Investors page for on-demand access following the event.

Where is the live audio webcast of InspireMD (NSPR) hosted for the April 14, 2026 presentation?

The live audio webcast and archive are hosted on InspireMD’s corporate Investors page at investors.inspiremd.com. According to InspireMD, the company will provide the webcast link and replay on that investor relations webpage.